Postoperative seizures in meningioma patients: improving patient selection for antiepileptic drug therapy
- PMID: 29959695
- PMCID: PMC6182382
- DOI: 10.1007/s11060-018-2941-2
Postoperative seizures in meningioma patients: improving patient selection for antiepileptic drug therapy
Abstract
Background: Epilepsy is a major cause of morbidity and mortality in meningioma patients. The aims of this study were to determine which factors predispose meningioma patients to developing perioperative seizures and to understand the impact of antiepileptic drugs.
Methods: Patients treated for a histologically-confirmed intracranial meningioma at the authors' institution between 2010 and 2015 were retrospectively examined. Clinical and imaging data were assessed. Multivariate analysis was performed using binary logistic regression. The effect of antiepileptic treatment was assessed using survival analysis.
Results: Two hundred and eighty-three patients met the selection criteria; seizures were present in 68 preoperatively (24%) and in 48 patients (17%) following surgery. Of the 68 with preoperative seizures, 19 continued to have them, whereas de-novo seizures arose postoperatively in 29 seizure-naïve patients. Risk factors of postoperative seizures were convexity location (OR 2.05 [95% CI 1.07-3.98], p = 0.030), fronto-parietal location (OR 4.42 [95% CI 1.49-13.16], p = 0.007) and preoperative seizures (OR 2.65 [95% CI 1.37-5.24], p = 0.005). The two locations, in addition to the presence of midline shift on preoperative imaging (OR 4.15 [95% CI 1.54-11.24], p = 0.005), were significantly correlated with postoperative seizures in seizure-naïve patients. Antiepileptic treatment in patients with those risk factors reduced the possibility of seizures at any time point within the 1st year postoperatively by approximately 40%, although this did not meet statistical significance.
Conclusion: Prophylactic antiepileptic treatment might be warranted in seizure-naïve meningioma patients with ≥ 1 risk factor. High-quality randomised controlled trials are required to verify those factors and to define the role of antiepileptics in meningioma practice.
Keywords: Antiepileptic drugs; Epilepsy; Meningioma; Post-operative seizure.
Conflict of interest statement
Disclosures
A.I.I, A.A, A.B, M.U.A, S.J.M, E.C, A.R.B and M.D.J have no relevant disclosures to report.
Ethical approval
The Institutional Review Board at the Walton Centre NHS Foundation Trust approved this study. For this type of study formal patient consent is not required.
Figures
Similar articles
-
Risk Factors of Preoperative and Early Postoperative Seizures in Patients with Meningioma: A Retrospective Single-Center Cohort Study.World Neurosurg. 2017 Jan;97:538-546. doi: 10.1016/j.wneu.2016.10.062. Epub 2016 Oct 21. World Neurosurg. 2017. PMID: 27777150
-
Long-term control and predictors of seizures in intracranial meningioma surgery: a population-based study.Acta Neurochir (Wien). 2018 Mar;160(3):589-596. doi: 10.1007/s00701-017-3434-3. Epub 2018 Jan 11. Acta Neurochir (Wien). 2018. PMID: 29327143
-
Preoperative antiepileptic drug prophylaxis for early postoperative seizures in supratentorial meningioma: a single-center experience.J Neurooncol. 2022 May;158(1):59-67. doi: 10.1007/s11060-022-04009-4. Epub 2022 Apr 17. J Neurooncol. 2022. PMID: 35434765 Review.
-
Postoperative seizures following the resection of convexity meningiomas: are prophylactic anticonvulsants indicated? Clinical article.J Neurosurg. 2011 Mar;114(3):705-9. doi: 10.3171/2010.5.JNS091972. Epub 2010 Jun 25. J Neurosurg. 2011. PMID: 20578801
-
Seizures in meningioma.Handb Clin Neurol. 2020;170:187-200. doi: 10.1016/B978-0-12-822198-3.00053-7. Handb Clin Neurol. 2020. PMID: 32586490 Review.
Cited by
-
Perioperative levetiracetam for seizure prophylaxis in seizure-naive brain tumor patients with focus on neurocognitive functioning.BMC Neurol. 2022 Jul 8;22(1):250. doi: 10.1186/s12883-022-02762-7. BMC Neurol. 2022. PMID: 35804291 Free PMC article.
-
Clinical management of seizures in patients with meningiomas: Efficacy of surgical resection for seizure control and patient-tailored postoperative anti-epileptic drug management.Neurooncol Adv. 2023 Jun 3;5(Suppl 1):i58-i66. doi: 10.1093/noajnl/vdac136. eCollection 2023 May. Neurooncol Adv. 2023. PMID: 37287578 Free PMC article.
-
Meningioma: International Consortium on Meningiomas consensus review on scientific advances and treatment paradigms for clinicians, researchers, and patients.Neuro Oncol. 2024 Oct 3;26(10):1742-1780. doi: 10.1093/neuonc/noae082. Neuro Oncol. 2024. PMID: 38695575 Free PMC article. Review.
-
Impact of meningioma surgery on use of antiepileptic, antidepressant, and sedative drugs: A Swedish nationwide matched cohort study.Cancer Med. 2021 May;10(9):2967-2977. doi: 10.1002/cam4.3868. Epub 2021 Mar 26. Cancer Med. 2021. PMID: 33773085 Free PMC article.
-
Predictors of Postoperative Epilepsy/Seizures in Patients Readmitted After Meningioma Resection.Behav Neurol. 2025 Jul 9;2025:5717503. doi: 10.1155/bn/5717503. eCollection 2025. Behav Neurol. 2025. PMID: 40677941 Free PMC article.
References
-
- Wu A, Garcia MA, Magill ST, Chen W, Vasudevan HN, Perry A, et al. Presenting symptoms and prognostic factors for symptomatic outcomes following resection of meningioma. World Neurosurg. 2017 - PubMed
-
- Weston J, Greenhalgh J, Marson AG. Antiepileptic drugs as prophylaxis for post-craniotomy seizures. Cochrane Database Syst Rev. 2015;3:Cd007286. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous